Clincosm LogoSign in Get a demo

Advanced Solid Tumors

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +10 more
Jun 6, 2023

Advanced Solid Tumors Trial in Worldwide (BMS-986449, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Los Angeles, California
  • +19 more
May 25, 2023

Advanced Solid Tumors Trial in Worldwide (AMG 650)

Active, not recruiting
  • Advanced Solid Tumors
  • AMG 650
  • Los Angeles, California
  • +21 more
Jan 26, 2023

Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +39 more
Jan 25, 2023

Advanced Solid Tumors Trial in Worldwide (PDR001)

Recruiting
  • Advanced Solid Tumors
  • New York, New York
  • +42 more
Jan 23, 2023

Advanced Solid Tumors Trial in Santa Monica, Oklahoma City (ADCT-601, Gemcitabine)

Recruiting
  • Advanced Solid Tumors
  • Santa Monica, California
  • +9 more
Jan 19, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +41 more
Jan 10, 2023

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)

Not yet recruiting
  • Advanced Solid Tumors
  • Madrid, M, Spain
  • +1 more
Dec 23, 2022

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

Recruiting
  • Advanced Solid Tumors
  • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
  • Tucson, Arizona
  • +83 more
Dec 28, 2022

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
Nov 23, 2022

Lymphoma, Advanced Solid Tumors Trial in Worldwide (E7766)

Completed
  • Lymphoma
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +12 more
Oct 21, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • OMO-103
  • Barcelona, Spain
  • +2 more
Sep 27, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • Los Angeles, California
  • +31 more
Jul 20, 2022

NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Santa Monica, California
  • +25 more
Jun 27, 2022

Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)

Recruiting
  • Advanced Solid Tumors
  • Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
  • Ghent, Belgium
  • +2 more
Jun 23, 2022

Advanced Solid Tumors Trial in Worldwide (ASP8374, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +53 more
May 18, 2022

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022